DoT relaxes work from home norms till July 31

Earlier, DoT has relaxed the norms till April 30, 2020.

Moneycontrol News

April 29, 2020 / 07:26 AM IST

The Department of Telecommunication (DoT) has relaxed norms for facilitating work from home (WFH) for IT firms till July 30, 2020 at the back of COVID-19 outbreak.

Earlier, DoT relaxed the norms till April 30, 2020.

This means companies can now ask its employees to work from home till July. They can also start operations with 50 percent of the work force. Most IT majors have said that the company will increase office operations slowly with 5 percent of employees and slowly increase. Others are yet to communicate to their employees.

In a tweet, Union IT minister Ravi Shankar Prasad said, “In response to IT Industry’s request to facilitate WFH for OSPs, @DoT_India had relaxed terms & conditions for VPN till 30.4.20. After discussions with IT Ministers this relaxation in terms and conditions is extended till 31.7.20.”

Wish to clarify that it is not extension of #WFH.
In response to IT Industry’s request to facilitate WFH for OSPs, @DoT_India had relaxed terms & conditions for VPN till 30.4.20.
After discussions with IT Ministers this relaxation in terms & conditions is extended till 31.7.20 https://t.co/UwSH704xc5

— Ravi Shankar Prasad (@rsprasad) April 28, 2020

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show